JUN 05, 2019 05:01 PM PDT

Additional drug in hormone therapy for breast cancer extends women's lives

The findings from a new clinical trial were presented this week at the American Society of Clinical Oncology annual meeting in Chicago. The trial showed that the addition of a drug called Kisqali (ribociclib) to standard hormone therapy has the capability of lengthening the lives of younger women with advanced breast cancer. The trial’s findings will be published in the New England Journal of Medicine.

The trial was led by Dr. Debu Tripathy, chair of the breast medical oncology department at M.D. Anderson Cancer Center in Houston. All of the women participating in the trial received standard hormonal therapy, in addition to a medication that turns off the ovaries' production of estrogen. Dr. Tripathy’s team also gave half of the women Kisqali and half a placebo.

Kisqali is taken as a tablet and is in a class of drugs called CDK4/6 inhibitors; it functions by blocking two proteins that help cancer cells grow and divide.

The trial found that on average, the women who received Kisqali lived six months longer than women in the control group. After 3.5 years, 70% of patients given hormone therapy plus Kisqali were still alive, compared to 46% of those given hormone therapy alone.

"In reality, what this means is if we get a confirmation from the bigger trial, then this could well lead to a change in the standard of care across the world,” said Dr. Rob Jones, trial co-leader and a consultant in oncology. "When you're given a diagnosis of cancer that is incurable, any extension of life is incredibly important," he added. "We've talked about averages but there are plenty of examples in the trial of patients who have lived for two or three years without their disease yet progressing."

Kisqali could extend the lives of women with advanced breast cancer. Photo: Pixabay

The researchers hope that this trial will provide enough evidence to make significant changes in the standard of care offered to premenopausal women with advanced breast cancer. They hope it will extend worldwide.

Sources: BBC, CBS News

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUN 20, 2019
Cancer
JUN 20, 2019
Doctors Find New Test for Brain Cancer
Doctors from the Memorial Sloan Kettering Cancer Center in New York recently published a paper in Nature detailing what they believe is a novel,...
JUN 20, 2019
Cancer
JUN 20, 2019
How Long Has Cancer Been Around?
Cancer is on everybody's mind these days. Many pharmaceutical companies are devoted solely to finding new cancer treatments. In 2016, President Obama c...
JUN 20, 2019
Drug Discovery
JUN 20, 2019
PARP Inhibitors Boost Immune Efficacy
In a recent research study, precision cancer drugs called PARP inhibitors are previously known to boost the immune system were found to spark a powerful im...
JUN 20, 2019
Cancer
JUN 20, 2019
Cancer Patients Increase Cannabis Use 118 Percent in Nine Years
Between 2005 and 2014, cancer patients increased their use of marijuana/ cannabis 114 percent, according to a new study from researchers at the University ...
JUN 20, 2019
Cancer
JUN 20, 2019
A Call to Reduce Mohs Skin Cancer Surgery: Doctors Respond to Peer Letters
Skin cancer treatment and surgery options vary widely. Even within one method, patients’ needs and surgeons’ choices differ. A recent stud...
JUN 20, 2019
Cancer
JUN 20, 2019
Uterine Cancer Rises, Especially Among Black Women
A recent study from the National Cancer Institute (NCI) found uterine cancer rates among all women rose about 1 percent per year between 2003 and 2015. It&...
Loading Comments...